Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas - Wikidata - awgldk - TriplyDB

Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas

Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas

http://www.wikidata.org/entity/Q34725017

about

A review of the past, present, and future directions of neoplasia Neoplasia: Where We Have Been and Where We Are Going An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.Antitumor activity of 7-O-succinyl macrolactin A tromethamine salt in the mouse glioma model.Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer models.Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma.Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model.Oncolytic viral therapy of malignant glioma Adenovirus with DNA Packaging Gene Mutations Increased Virus Release.Viruses, gene therapy and stem cells for the treatment of human glioma.Combination treatment for glioblastoma cells with tumor necrosis factor-related apoptosis-inducing ligand and oncolytic adenovirus delta-24.A one-step ligation system for rapid generation of armed, conditionally-replicating adenoviruses.Gene therapy for malignant glioma.Neoplasia: An Anniversary of Progress.Gene therapy and targeted toxins for glioma

P2860

Q28389391-11802400-17D6-48E8-BCA8-550CB6EBE154 Q28395095-B9A7DC04-9E8B-4FDF-A7B8-EEA9F158000B Q30432036-5C4D1F48-942A-4AD6-971B-1BF9FEDAECF4 Q33685664-E71CF031-5832-4326-AA3D-A24994038A86 Q33828114-E851694B-384C-4678-B17C-A3DC34EB3CBF Q34293923-9940630C-C1C4-43DD-95D0-D6DB27A6EDCE Q35036505-0E803B1E-9940-47A9-BECE-2073F250C04B Q36096024-8FE96BA4-CF76-4801-9275-C82CFDBEA610 Q36634430-9E6A5440-3EF1-447E-AC75-B1AB6D16DC2C Q36658322-E180B242-BA3B-43FC-9793-94E6E69AA87E Q36738884-47C1C8A5-F4CF-41B3-9BDA-A82338AFE0B1 Q37010979-A07E8EC1-DA8D-4B7C-916E-0AD244C8AB16 Q37533665-0E4F409F-E0E0-42B5-A564-AF82C58C479D Q37539305-06AB0ED6-E372-4A30-A1EF-B2A85D748751 Q37567452-50B33080-E277-4E8D-BD1F-4472251D90D1 Q39069742-582DEF2B-5DA0-465A-85CA-EE9E79DE30FC Q44607522-49DBB018-4ED6-4A06-B005-3510F595321B Q45857497-EB90F109-AC0F-4060-B0DC-F2FA15DF9A26 Q46932476-8EAE0C7C-7F0E-43E4-96D6-80C276BA3F9B Q57006162-00D52F63-A1F8-4362-BDC1-434CD44A1737

P2860

Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas

http://www.wikidata.org/entity/Q34725017

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Comparative effect of oncolyti ...... deletions in malignant gliomas

@ast

Comparative effect of oncolyti ...... deletions in malignant gliomas

@en

Comparative effect of oncolyti ...... deletions in malignant gliomas

@nl

type

label

Comparative effect of oncolyti ...... deletions in malignant gliomas

@ast

Comparative effect of oncolyti ...... deletions in malignant gliomas

@en

Comparative effect of oncolyti ...... deletions in malignant gliomas

@nl

prefLabel

Comparative effect of oncolyti ...... deletions in malignant gliomas

@ast

Comparative effect of oncolyti ...... deletions in malignant gliomas

@en

Comparative effect of oncolyti ...... deletions in malignant gliomas

@nl

P1433

Q34725017-46CA400D-D7E1-4862-B615-A5987E4939D5

P1476

Q34725017-F8974F0B-3389-47C7-8987-7D8FF7E33B7F

P2093

Q34725017-2BED63AA-3943-4B2B-BDD0-C455B620318A

Q34725017-2C919F4B-D4B8-4281-8D09-DD49490A4AD4

Q34725017-3359A97F-A399-4B91-96B7-D5A97DBAF0C0

Q34725017-5A27DE2B-32C0-48C9-B2D4-DD4458ED3437

Q34725017-897FE57E-ED70-47B4-BDE4-9FF49DF9ED03

Q34725017-C3824EB8-1498-44EE-B5E0-4771846ED45C

Q34725017-CC219946-FE7B-4909-950A-DC0843D8D06A

Q34725017-D2378542-830C-48AB-9ED3-5BA04295126E

Q34725017-D36D82DB-CACF-43DB-BF91-CD09E9221006

Q34725017-FE3EE063-CEB2-4306-892F-45FD7412561A

P2860

Q34725017-04922681-9E6A-466C-81BF-BA44AAE7B985

Q34725017-19B7600F-CB81-4421-A25C-D8AB56B50BCD

Q34725017-23257BD6-6832-4A27-9890-58C0124BB9D9

Q34725017-2444839D-100F-4D52-8F80-E6BB8963DF5A

Q34725017-2ABF18E7-9AEE-4231-B683-331B3C7C2E99

Q34725017-345191CA-396C-454B-9729-8E691FE660FF

Q34725017-3D9B45C1-A877-49A6-9006-4ABE37923834

Q34725017-435D376A-C25E-4258-B078-72437588BDCC

Q34725017-56DA5DE3-2082-452F-9441-2B08C840D3DF

Q34725017-5B58B7E8-9663-475B-B61E-23DFB4FD54BD

P304

Q34725017-0451F27B-1E9F-46AF-BE1A-70FCA9ACB53B

P31

Q34725017-D81F79F3-B922-4654-B589-0AF631425519

P356

Q34725017-1D7B852F-B62B-4A50-816C-E3E4975E4C9A

P433

Q34725017-4D5B639A-F92F-40B4-A234-3518F3234517

P478

Q34725017-C545AA5C-A0A7-4AD7-84D1-A20933BFABC9

P577

Q34725017-8DC22CA7-03DF-42D8-B18E-A72B954F9758

P5875

Q34725017-B8579F8B-389F-4AE6-B9AF-26EBFFBE939C

P698

Q34725017-84ED898F-5362-42FD-9343-0EC874A8E7FD

P921

Q34725017-064E411D-8FC1-4B02-9449-A326A57545DE

Q34725017-A34612A3-0063-410A-9B5E-1E6DA5724DCF

P932

Q34725017-FFC34E48-C842-4EA9-BA8A-EF2A2B2CE4C1

P356

P1433

P1476

Comparative effect of oncolyti ...... deletions in malignant gliomas

@en

P2093

B Nebiyou Bekele

http://www.w3.org/2001/XMLSchema#string

Candelaria Gomez-Manzano

http://www.w3.org/2001/XMLSchema#string

Charles C Conrad

http://www.w3.org/2001/XMLSchema#string

Diana Medrano

http://www.w3.org/2001/XMLSchema#string

E Lin

http://www.w3.org/2001/XMLSchema#string

Hong Jiang

http://www.w3.org/2001/XMLSchema#string

Juan Fueyo

http://www.w3.org/2001/XMLSchema#string

Marta Alonso

http://www.w3.org/2001/XMLSchema#string

Ramon Alemany

http://www.w3.org/2001/XMLSchema#string

W K Alfred Yung

http://www.w3.org/2001/XMLSchema#string

P2860

Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.

Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence.

Replicative adenoviruses for cancer therapy.

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

Malignant glioma: genetics and biology of a grave matter.

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection.

Manipulation of adenovirus vectors.

The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs.

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo.

P304

48-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.04391

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8012249

http://www.w3.org/2001/XMLSchema#string

P698

15720816

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

1490320

http://www.w3.org/2001/XMLSchema#string